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To the Editor: By adding ethylene glycol to the drinking
water of rats, and by quantifying oxaluria, crystalluria, and
renal crystal content and tissue distribution at different time
points after the ethylene glycol load, Vervaet et al.1 showed
that progression of the so-induced nephrocalcinosis not only
depends on the extent, rate, and duration of intratubular
crystal adhesion, but is countered by a post-adhesion crystal-
clearing mechanism, which might exert a protective effect on
the progression toward renal failure.
As the authors state, ‘renal calcium deposits were visualized
by von Kossa staining’. This stain works on the principle that
the positively charged silver ions, contained in the staining
solution, bind to the (anionic) negatively charged phosphate
ions, and apparently not to oxalate.2,3 The comparatively high
phosphate concentration and the predominance of calcium
phosphate deposits in the body, respectively, may explain why
other phosphate–containing salts (e.g., sodium phosphate) do
not give positive reactions, and why von Kossa staining is often
cited as specific for calcium deposits.1,3 Although ethylene
glycol increases oxaluria and crystalluria, Evan et al4 showed
that in intestinal bypass patients, despite hyperoxaluria, the
initial intraluminal crystals contained calcium phosphate
(apatite), suggesting that contact with urine supersaturated
with calcium oxalate would promote heterologous nucleation.
Vervaet et al.1 do not give any information about the compo-
sition of the von Kossa–positive deposit. However, characteriza-
tion of the intraluminal and interstitial deposits, for instance, by
subjecting the tissue to X-ray diffraction analysis, would have
added highly valuable information to this interesting study.
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We thank Dr Freudiger for his pertinent remark1 concerning
our publication.2 It raised several interesting issues.
First, in our paper we indeed did not pay attention to
the identification of the renal mineral deposits induced by
ethylene glycol (EG). To our knowledge, it has been
confirmed by polarized microscopy and X-ray powder
diffraction that EG administration results in calcium
oxalate (CaOx) crystal formation/retention.3 Nevertheless,
we would like to add here that the renal crystals in our
study also were birefringent, characteristic of CaOx
monohydrate (Figure 1a). However, in the context of the
reported crystal-clearing mechanism, the type of mineral
does not seem to be involved in initiating this mechanism,
as epithelial overgrowth of adhered crystals is observed for
adenine, calcium phosphate (CaP), and CaOx crystals.2
This suggests that epithelial overgrowth might be primar-
ily triggered by physical interaction of a solid structure
with the epithelium.
Second, we acknowledge that the von kossa stain,
which is based on a ‘metal substitution’ reaction, is
referred to as CaP-specific. Yet, in our experience we found
that the von kossa method also stains CaOx crystals. This
could raise questions regarding either the nature of the
mineral deposit or the staining protocol. As we are fairly
confident that we are dealing with CaOx crystals, we tested
the staining procedure. The key step in the von kossa
protocol is the reduction of silver to a black deposit.
Reduction is usually achieved by exposure to light for a
minimum of 20 min (UV lamp, bulb light, or even
daylight), however, it can also be rapidly achieved by
chemical reductors such as hydroquinone or pyrogallic
acid. To address the von kossa specificity issue, we
compared the two types of protocols: one with reduction
by light (UV), the other with reduction by use of 1%
pyrogallic acid (our standard protocol). We stained (1)
kidney sections presenting nephrocalcinosis, available
from rats injected intraperitoneally with NaOx, an
established model resulting in renal CaOx crystal deposi-
tion as confirmed by X-ray and polarized microscopy,4 and
(2) arterial CaP plaques of rats presenting vascular
calcifications because of adenine-induced renal insuffi-
ciency.5 We found that our protocol (pyrogallic acid)
stained both CaOx and CaP, whereas the UV protocol
stained only CaP (Figure 1b and c). Thus, silver is
apparently able to substitute for calcium even in CaOx
crystals; however, it seems to get reduced and/or locked in
place only when reduction is fast enough.
Third, we acknowledge that the findings of Evan
et al.6—that is, intratubular CaP crystals in intestinal
bypass patients presenting hyperoxaluria—are intriguing;
however, we have our doubts about whether short-term EG
administration is an appropriate model for intestinal
bypass–associated intratubular nephrocalcinosis with re-
spect to the crystal type. EG administration for up to 4
weeks did not reveal CaP crystals,3 and even in an
experimental rat model of intestinal bypass through
jejuno–ileal resection, intratubular CaOx crystals
were observed up to 12 weeks after surgery, whereas
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CaP crystals were never found.7 Probably, these experi-
mental time frames are too short for CaP crystallization
to occur.
Fourth, we agree that X-ray diffraction analysis can add
valuable information to the field of nephrocalcinosis. In
fact, we were recently allowed to carry out a lX-ray
diffraction study in our recent EG experiment2 at the
European Synchrotron Radiation Facility in Grenoble to
search for structural differences between intratubular and
interstitial crystals. Although data analysis is ongoing, we
found that the crystals indeed are composed of CaOx.
Whether CaP is completely absent or is present in trace
amounts, still has to be assessed for this study.
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Figure 1 | Identification of calcium oxalate and calcium phosphate crystals. (a) Renal tissue of a rat 2 days after arrest of a 4-day period of
EG administration.2 Birefringent crystals, indicative of CaOx monohydrate, are observed under polarized light microscopy (100, inset 630).
(b and c) Von kossa staining of CaOx and CaP mineral containing tissue by two protocols with different silver reductors, pyrogallic acid or UV.
(b) Serial sections of renal tissue with nephrocalcinosis of a rat intraperitoneally injected with sodium oxalate. (c) Serial sections of an artery
showing CaP plaque of animals with adenine-induced chronic renal failure. All renal sections were counterstained with hematoxylin/eosin.
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